% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • medicoinvestor Dec 12, 2012 10:38 AM Flag

    New Chinese patent closes door on Abbott

    A new formidable market of +1,3 billion inhabitants is now open to BioPorto via the Chinese (PRC) issuing of the crucial cut-off patent (250 ng/ml) – The patent protected blockbustercandidate The NGAL Test now rules supreme in China – India, Europe (the EPO-area)- and South Africa and, and, and…

    But even though India and other subcontinenents/areas/countries are important – China is, in this respect, the jewel in the crown. Oh – and then there is the pending Patent Applications in The US (USPTO) and Canada – but otherwise World Domination

    Abbott has for almost two years been pursuing the Chinese Market - looks as if that door is now slammed in the face...

    Read all about kidney testing with NGAL, the worlds next blockbuster

    SortNewest  |  Oldest  |  Most Replied Expand all replies
42.33+0.65(+1.56%)Sep 27 4:02 PMEDT